Eversept Partners’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.6M | Buy |
1,902,539
+524,865
| +38% | +$7.34M | 2.45% | 9 |
|
|
2025
Q1 | $18.6M | Buy |
1,377,674
+597,676
| +77% | +$8.06M | 1.89% | 16 |
|
|
2024
Q4 | $15M | Buy |
779,998
+88,766
| +13% | +$1.7M | 1.33% | 15 |
|
|
2024
Q3 | $15.7M | Buy |
691,232
+123,745
| +22% | +$2.82M | 1.08% | 20 |
|
|
2024
Q2 | $7.38M | Buy |
567,487
+425,412
| +299% | +$5.53M | 0.51% | 32 |
|
|
2024
Q1 | $2.49M | Buy |
142,075
+4,732
| +3% | +$82.9K | 0.17% | 56 |
|
|
2023
Q4 | $2.99M | Sell |
137,343
-305,927
| -69% | -$6.66M | 0.26% | 42 |
|
|
2023
Q3 | $6.8M | Buy |
+443,270
| New | +$6.8M | 0.58% | 28 |
|
|
2022
Q4 | – | Sell |
-478,387
| Closed | -$9.81M | – | 73 |
|
|
2022
Q3 | $9.81M | Buy |
478,387
+32,795
| +7% | +$673K | 0.85% | 22 |
|
|
2022
Q2 | $5.16M | Buy |
445,592
+289,849
| +186% | +$3.35M | 0.37% | 40 |
|
|
2022
Q1 | $2.88M | Sell |
155,743
-38,846
| -20% | -$718K | 0.22% | 48 |
|
|
2021
Q4 | $3.85M | Buy |
194,589
+34,589
| +22% | +$684K | 0.25% | 55 |
|
|
2021
Q3 | $2.63M | Buy |
+160,000
| New | +$2.63M | 0.18% | 56 |
|